Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Scaggiante

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|March 18, 2024
Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancerNicola Pavan, Bruna Scaggiante
World Journal of Gastroenterology|July 1, 2024
New challenges in hepatocellular carcinoma: A role for PIWI-interacting RNAs?Domenico Tierno, Gabriele Grassi, Bruna Scaggiante
Biochimie|August 2, 2005
Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cellsBruna Scaggiante, Barbara Dapas, Laura Perissin, et al.
Hematological Oncology|August 30, 2012
The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblastsBruna Scaggiante, Barbara Dapas, Gabriele Pozzato, et al.
The FEBS Journal|May 13, 2006
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell linesBruna Scaggiante, Barbara Dapas, Gabriele Grassi, et al.
International Journal of Molecular Sciences|March 13, 2025
Circulating Tumour DNA for Ovarian Cancer Diagnosis and Treatment Monitoring: What Perspectives for Clinical Use?Du-Bois Asante, Domenico Tierno, Gabriele Grassi, et al.
International Journal of Molecular Sciences|June 19, 2024
Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?Du-Bois Asante, Domenico Tierno, Michael Woode, et al.
Metabolism: Clinical and Experimental|November 14, 2007
Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patientsAlessandra Bosutti, Bruna Scaggiante, Gabriele Grassi, et al.
World Journal of Clinical Oncology|August 22, 2020
Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancerNavid Sobhani, Marianna Sirico, Daniele Generali, et al.
World Journal of Clinical Oncology|April 14, 2018
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?Navid Sobhani, Daniele Generali, Fabrizio Zanconati, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|March 18, 2024
Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancerNicola Pavan, Bruna Scaggiante
World Journal of Gastroenterology|July 1, 2024
New challenges in hepatocellular carcinoma: A role for PIWI-interacting RNAs?Domenico Tierno, Gabriele Grassi, Bruna Scaggiante
Biochimie|August 2, 2005
Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cellsBruna Scaggiante, Barbara Dapas, Laura Perissin, et al.
Hematological Oncology|August 30, 2012
The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblastsBruna Scaggiante, Barbara Dapas, Gabriele Pozzato, et al.
The FEBS Journal|May 13, 2006
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell linesBruna Scaggiante, Barbara Dapas, Gabriele Grassi, et al.
International Journal of Molecular Sciences|March 13, 2025
Circulating Tumour DNA for Ovarian Cancer Diagnosis and Treatment Monitoring: What Perspectives for Clinical Use?Du-Bois Asante, Domenico Tierno, Gabriele Grassi, et al.
International Journal of Molecular Sciences|June 19, 2024
Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?Du-Bois Asante, Domenico Tierno, Michael Woode, et al.
Metabolism: Clinical and Experimental|November 14, 2007
Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patientsAlessandra Bosutti, Bruna Scaggiante, Gabriele Grassi, et al.
World Journal of Clinical Oncology|August 22, 2020
Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancerNavid Sobhani, Marianna Sirico, Daniele Generali, et al.
World Journal of Clinical Oncology|April 14, 2018
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?Navid Sobhani, Daniele Generali, Fabrizio Zanconati, et al.
Pageof 6